Pharmaceutical Industry Market Research Reports, May 2013

Export (harmonized System): Pharmaceutical Products

• Industry data
• April 2013

Monthly, From 1992 To 2013
Source: U.S. Department of Labor: Bureau of Labor Statistics

• Industries : Pharmaceutical
• Countries : United States

Export (end Use): Medicinal, Dental, And Pharmaceutical Preparatory Materials

• Industry data
• April 2013

Monthly, From 1985 To 2013
Source: U.S. Department of Labor: Bureau of Labor Statistics

• Industries : Pharmaceutical
• Countries : United States

Import (end Use): Medicinal, Dental And Pharmaceutical Preparatory Materials

• Industry data
• April 2013

Monthly, From 1992 To 2013
Source: U.S. Department of Labor: Bureau of Labor Statistics

• Industries : Pharmaceutical
• Countries : United States

Import (harmonized System): Pharmaceutical Products

• Industry data
• April 2013

Monthly, From 1992 To 2013
Source: U.S. Department of Labor: Bureau of Labor Statistics

• Industries : Pharmaceutical
• Countries : United States

Company Report: Pathology in France for Year 2013

• Company report
• May 2013
• 32 pages
• by Corporation

... That dicobalt edetate only be given when the patient is tending to lose or has lost consciousness. Distamine penicillamine a disease modifying antirheumatic drug (dmard) used for the treatment of rheumatoid ...

• Industries: Pathology
• Countries: France

VIVUS Inc. - Company Report for Year 2013

• Company report
• May 2013
• 2 pages
• by Corporation

• Industries: Pathology
• Countries: United States

Company Report: Pathology in The United States for Year 2013

• Company report
• May 2013
• 6 pages

• Industries: Pathology
• Countries: World, United States

Company Report: Drug for Year 2013

• Company report
• April 2013
• 23 pages

• Industries: Drug and Medication

Perrigo Co. - Company Report for Year 2013

• Company report
• May 2013
• 26 pages

• Industries: Pharmaceutical

Company Report: Pathology in The United States for Year 2013

• Company report
• April 2013
• 6 pages

• Industries: Pathology
• Countries: United States

Company Report: Pharmacies and Drug Stores in The United States for Year 2013

• Company report
• April 2013
• 5 pages

... With congress, the department of health and human services (hhs), patients, and other healthcare providers to improve the quality and affordability of healthcare services. Nacds represents trional drug ...

• Industries: Pharmacies and Drug Stores
• Countries: United States

Company Report: Generic Drug in Singapore, South Korea and The United States for Year 2013

• Company report
• April 2013
• 3 pages
• by Corporation

• Industries: Generic Drug
• Countries: Singapore, South Korea, United States

Merck Research Laboratories - Company Report for Year 2013

• Company report
• April 2013
• 62 pages

... Such as cancer, cardiovascular and infectious diseases, thereby allowing early treatment. Predominantly, elisa-based tests are used to monitor various disease biomarkers. However, these tests can measure only ...

• Industries: Pathology
• Countries: United States

Company Report: Drug Delivery in Australia and The United States for Year 2013

• Company report
• May 2013
• 21 pages

... Of imugene platform linguet Is a proprietary drug delivery technology that improves the efficacy and safety of a diverse number of prescription and over the counter medicines. The platform technology ...

• Industries: Drug Delivery Technology
• Countries: Australia, United States

Lorus Therapeutics Inc. - Company Report for Year 2013

• Company report
• April 2013
• 5 pages

... Of additional quantities of lor-253, increased clinical costs associated with the lor-253 phase i clinical trial as well as spending on our il-17e and lor-500 programs initiated and escalated in the current ...

• Industries: Drug Discovery and Development
• Countries: United States, Canada

Company Report: Pathology in The United States and Ireland for Year 2013

• Company report
• May 2013
• 5 pages
• by Corporation

... Involved, even indirectly, with an important therapeutic area that addresses the needs of millions of patients who suffer from respiratory disease is particularly meaningful to all of us at elan." Relvar ...

• Industries: Pathology
• Countries: United States, Ireland

Company Report: Pathology in The United States for Year 2013

• Company report
• May 2013
• 9 pages

• Industries: Pathology
• Countries: World, United States

Company Report: Therapeutics in The United States for Year 2013

• Company report
• May 2013
• 46 pages

... On applying gene therapy technology to genetically modify a patient S own t-cells, known as chimeric antigen receptor (car) t-cells, to target and destroy cancer cells. Celgene has an option to license any ...

• Industries: Therapy
• Countries: United States

Company Report: Pathology in The United States for Year 2013

• Company report
• May 2013
• 9 pages

... Stribild gilead hiv-1 infection aug. 27 Neutroval sicor biotech neutropenia aug. 29 Linzess forest ibs aug. 30 Xtandi astellas prostate cancer aug. 31 Bosulif pfizer leukemia sep. 4 Aubagio sanofi multiple ...

• Industries: Pathology
• Countries: World, United States

The Malaysian Pharmaceutical Business Analysis

• Industry report
• April 2013
• 56 pages

... Or contraception for good family planning and avoidance of sti To strengthen antenatal care among teenagers in order to reduce complications eg anemia To encourage them to come for booking or check up ...

• Industries: Pathology
• Countries: Malaysia

Diabete Market Analysis (diabete, obesity, angina pectoris) in The United States

• Industry report
• April 2013
• 56 pages

• Industries: Pathology
• Countries: United States

Drug Discovery and Development Sector in The United States and Singapore

• Industry report
• April 2013
• 22 pages

... Progression modelling at gsk, uk and chdr, the netherlands danny lowe, cfo part time: previously cfo for several public companies in the drug discovery, alternative energy and mineral resources sector advisors ...

• Industries: Drug Discovery and Development
• Countries: United States, Singapore

Pharmaceutical Key Market Figures

• Industry report
• April 2013
• 19 pages
• by Corporation

• Industries: Pathology

The Swazi Pharmaceutical Industry

• Industry report
• May 2013
• 21 pages

... Production v livestock production v natural resources vdiscuss the roles of government on hiv/aids vdiscuss the roles of pepfar u.S government organization on hiv/aids vdiscuss the impact of hiv/aids ...

• Industries: Pathology
• Countries: Africa, World, Swaziland

U.S. Pharmaceutical Industry

• Industry report
• May 2013
• 46 pages

... Sorbentstm competition 38 no approved therapies in the eu or us to prevent or treat organ failure Sepsis Ards and ali Burn injury Trauma Severe acute pancreatitis Cardiopulmonary bypass ...

• Industries: Pathology
• Countries: United States

Cardiovascular Disease Sector Trends (cardiovascular disease, blood disease, endocrine, nutritional and metabolic diseases) in India

• Industry report
• April 2013
• 22 pages
• by Non Governmental Organization (NGO)

• Industries: Pathology
• Countries: India, World

Vaccine Market in Tanzania

• Industry report
• May 2013
• 11 pages

... Of a polio vaccine what does it take to vaccinate a child against polio This two-minute video from unicef shows us that the journey of a polio vaccine is an incredibly complex process. The menafrivac ctc ...

• Industries: Drug and Medication
• Countries: Tanzania, World

Prescription Drug Production and Trade Statistics in The United States

• Industry report
• May 2013
• 95 pages

• Industries: Prescription Drug
• Countries: United States

U.S. Vitamin D Sector Analysis

• Industry report
• May 2013
• 60 pages

... We know patients are deficient in it, so important to treat it anyway. Also why not have nonunion patients take a product that has: Calcium (dairy) vitamin k2 (natto, fermented cheese and organ ...

• Industries: Vitamin and Supplement
• Countries: United States

Drug Industry Analysis in The United States and Canada

• Industry report
• May 2013
• 51 pages

... To production interruptions and diminished capacity Economic choices are made where older, less profitable drugs are eliminated as new generics come to market By year-end 2012, we will see $34b in new ...

• Industries: Drug and Medication
• Countries: United States, Canada

U.S. Prescription Drug Industry Analysis

• Industry report
• April 2013
• 70 pages

... Key terminology prescription drug plan (pdp)-insurance plan used to cover prescription drugs as part of medicare part d Doughnut hole-point at which pdp stops offering coverage ...

• Industries: Prescription Drug
• Countries: United States

U.S. Brain Tumor Industry (brain tumor, glioblastoma)

• Industry report
• May 2013
• 24 pages

... Uncertainty was positively correlated to five poms-sf subscales, anger, confusion, depression, fatigue, and tension (all with p ...

• Industries: Pathology
• Countries: United States

Drug and Medication Sector in Malaysia

• Industry report
• May 2013
• 37 pages

... Adulterants were found to be therapeutic substances associated with the specific indications of the products such as adulterant for sexual enhancement drugs ( sildenafil, tadalafil ), pain relieving drugs ...

• Industries: Drug and Medication
• Countries: Malaysia

Pharmaceutical Key Market Figures

• Industry report
• April 2013
• 20 pages
• by Corporation

... Africa), latin america, canada, others *** >500% key products Mabthera/rituxan (+6%), for non-hodgkin S lymphoma (nhl), chronic lymphocytic leukemia (cll), rheumatoid arthritis, as well ...

• Industries: Pathology